Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05502315Phase 2Active Not Recruiting
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
Castration-resistant Prostate CancerMetastatic Cancer
PrincipalinvestigatorStart date: 2023-02-02

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05502315Phase 2PrincipalInvestigator

Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer

Castration-resistant Prostate CancerMetastatic Cancer
Active Not Recruiting
NCT05498272Phase 2PrincipalInvestigator

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations

BRCA1 MutationBRCA2 MutationHigh-Risk Cancer+2 more
Active Not Recruiting

All 2 trials loaded